Eli Lilly & Co.

LLYNYSE

Healthcare · Pharmaceutical Preparations

Market cap

$896.13B

Employees

50,000

Exchange

NYSE

Headquarters

INDIANAPOLIS, IN

About Eli Lilly & Co.

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Industry

Pharmaceutical Preparations

Sector

Healthcare

Country

US

Website

www.lilly.com